What is a recommended taper schedule for a patient taking 2 mg of Xanax (alprazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alprazolam (Xanax) Tapering Schedule from 2 mg

For patients taking 2 mg of alprazolam, the recommended tapering schedule is to reduce the dose by no more than 0.5 mg every 3 days, with slower reductions for elderly patients or those with advanced liver disease. 1

General Tapering Guidelines

  • Abrupt discontinuation of alprazolam should be avoided due to risk of withdrawal symptoms including seizures, rebound anxiety, insomnia, and in rare cases, status epilepticus 1
  • The FDA-approved tapering schedule recommends reducing alprazolam by no more than 0.5 mg every 3 days 1
  • Some patients may require an even slower taper, especially those who have been on the medication for a long time 1
  • If significant withdrawal symptoms develop during tapering, return to the previous well-tolerated dose before attempting a slower taper 1

Specific Tapering Schedule for 2 mg Alprazolam

Initial Phase (First 2-3 weeks):

  • Start with reducing from 2 mg to 1.5 mg daily for 3 days 1
  • Then reduce to 1 mg daily for the next 3 days 1
  • Further reduce to 0.5 mg daily for 3 days 1

Final Phase:

  • For the final 0.5 mg, consider an even slower taper, reducing by 0.25 mg every 3-7 days 1, 2
  • Some patients may benefit from an even more gradual discontinuation at this stage 1

Monitoring and Adjusting the Taper

  • Monitor for withdrawal symptoms including heightened sensory perception, impaired concentration, paresthesias, muscle cramps, diarrhea, blurred vision, anxiety, and insomnia 1
  • The risk of seizures appears greatest 24-72 hours after discontinuation, particularly with abrupt dose reduction 1
  • If interdose symptoms (anxiety between doses) occur, consider dividing the same total daily dose into more frequent administrations 1

Special Considerations

  • For elderly patients or those with advanced liver disease, start with a lower dose (0.25 mg) and taper even more gradually 1
  • Some patients may prove resistant to all discontinuation regimens and require specialized care 1
  • If withdrawal symptoms become severe, temporarily return to the previous well-tolerated dose before attempting a slower taper 3
  • Consider timing the final discontinuation when the patient has fewer life stressors 3

Adjunctive Treatments During Tapering

  • α2-agonists like clonidine can help mitigate physical withdrawal symptoms, though careful titration is needed due to potential hypotension 4
  • Tizanidine is less effective but also less likely to cause hypotension 4
  • For anxiety and insomnia during tapering, short-term use of trazodone, gabapentin, or mirtazapine may be beneficial 4
  • Cognitive behavioral therapy increases tapering success rates and may be particularly helpful for patients struggling with benzodiazepine tapering 4

Common Pitfalls to Avoid

  • Never abruptly discontinue alprazolam as this significantly increases risk of withdrawal seizures 1
  • Don't set arbitrary time limits for completing the taper; individualize based on patient response 3
  • Avoid converting to methadone for weaning due to complex pharmacokinetics and high lethality risk 4
  • Be aware that withdrawal symptoms may be mistaken for recurrence of the original condition, leading to unnecessary long-term medication 5

Remember that some patients may require 6 months or longer for a successful taper, especially those who have been on long-term therapy 4. The goal is to minimize withdrawal symptoms while safely discontinuing the medication.

References

Guideline

Tapering Protocol for Mirtazapine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.